Detalles de la búsqueda
1.
Cardiovascular Risk Factor Control and Lifestyle Factors in Young to Middle-Aged Adults with Newly Diagnosed Obstructive Coronary Artery Disease.
Cardiology
; 142(2): 83-90, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079098
2.
The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis.
Curr Atheroscler Rep
; 19(12): 48, 2017 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038899
3.
Lack of Evidence Linking Calcium With or Without Vitamin D Supplementation to Cardiovascular Disease in Generally Healthy Adults: A Clinical Guideline From the National Osteoporosis Foundation and the American Society for Preventive Cardiology.
Ann Intern Med
; 165(12): 867-868, 2016 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776362
4.
Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
Diabetes Metab Res Rev
; 31(6): 603-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25728823
5.
The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
Curr Atheroscler Rep
; 17(4): 494, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25690588
6.
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
Am Heart J
; 167(3): 342-349.e17, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576518
7.
Systematic review: Evaluating the effect of lipid-lowering therapy on lipoprotein and lipid values.
Cardiovasc Drugs Ther
; 27(5): 465-79, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23893306
8.
JCL Roundtable: From Gen Med to Clinical Lipidology.
J Clin Lipidol
; 17(2): 199-207, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965957
9.
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
J Am Heart Assoc
; 12(9): e029175, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119068
10.
A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
J Am Heart Assoc
; 11(6): e024176, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35232215
11.
Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management.
Curr Diab Rep
; 11(1): 64-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21104207
12.
JCL Roundtable: Global Think Tank on Lipoprotein(a).
J Clin Lipidol
; 15(3): 387-393, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34144765
13.
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER).
J Clin Lipidol
; 14(6): 807-817, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023859
14.
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association.
J Clin Lipidol
; 14(4): 398-413, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507592
15.
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards).
Circulation
; 127(9): 1052-89, 2013 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23357718
16.
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Atherosclerosis
; 289: 85-93, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487564
17.
Lowering LDL-Cholesterol and CV Benefits: Is There a Limit to How Low LDL-C Needs to be for Optimal Health Benefits?
Clin Pharmacol Ther
; 104(2): 290-296, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882959
18.
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics.
Am J Med
; 130(10): 1233, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28739196
19.
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.
Clin Cardiol
; 40(4): 243-254, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28328015
20.
Dapagliflozin in patients with type II diabetes mellitus, with and without elevated triglyceride and reduced high-density lipoprotein cholesterol levels.
J Clin Lipidol
; 11(2): 450-458.e1, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28502502